Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison

被引:60
作者
Harris, CL [1 ]
Hanna, SM [1 ]
Mizuno, M [1 ]
Holt, DS [1 ]
Marchbank, KJ [1 ]
Morgan, BP [1 ]
机构
[1] Univ Wales Coll Med, Dept Med Biochem & Immunol, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
基金
英国惠康基金;
关键词
D O I
10.1046/j.1365-2567.2003.01628.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD59, the sole membrane regulator of the membrane attack complex of complement, is broadly and abundantly expressed in man and other mammals. In mouse, CD59 is encoded by two homologous genes. The expression patterns and functional roles of the proteins encoded by these genes, mCD59a and mCD59b, have not been well characterized. Here we describe the generation of monoclonal and polyclonal antibodies detecting specifically mCD59a and mCD59b. These reagents have been used to study function and to ascertain the cell and tissue distributions of mCD59a and mCD59b. mCD59a was broadly distributed on endothelia, erythrocytes, platelets, and on numerous other cell types in organs, a distribution pattern resembling that of CD59 in other species. In marked contrast, expression of mCD59b was restricted to germ cell elements in the testis and mature spermatozoa. Both mCD59a and CD59b inhibited human and rodent complement with similar efficiency. These findings demonstrate that the broadly distributed mCD59a is the key regulator of the terminal complement pathway in mice whereas CD59b, expressed only in testis and on sperm, probably plays other roles in vivo.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 27 条
  • [1] THE PREPARATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO HUMAN-COMPLEMENT COMPONENT C8 AND THEIR USE IN PURIFICATION OF C8 AND C8 SUBUNITS
    ABRAHA, A
    MORGAN, BP
    LUZIO, JP
    [J]. BIOCHEMICAL JOURNAL, 1988, 251 (01) : 285 - 292
  • [2] Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59
    Bodian, DL
    Davis, SJ
    Morgan, BP
    Rushmere, NK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 507 - 516
  • [3] MEMBRANE DEFENSE AGAINST COMPLEMENT LYSIS - THE STRUCTURE AND BIOLOGICAL PROPERTIES OF CD59
    DAVIES, A
    LACHMANN, PJ
    [J]. IMMUNOLOGIC RESEARCH, 1993, 12 (03) : 258 - 275
  • [4] PRIMATE TERMINAL COMPLEMENT INHIBITOR HOMOLOGS OF HUMAN CD59
    FODOR, WL
    ROLLINS, SA
    BIANCOCARON, S
    BURTON, WV
    GUILMETTE, ER
    ROTHER, RP
    ZAVOICO, GB
    SQUINTO, SP
    [J]. IMMUNOGENETICS, 1995, 41 (01) : 51 - 51
  • [5] FUNABASHI K, 1994, IMMUNOLOGY, V81, P444
  • [6] Hanna SM, 1998, IMMUNOLOGY, V95, P450
  • [7] Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities
    Harris, CL
    Spiller, OB
    Morgan, BP
    [J]. IMMUNOLOGY, 2000, 100 (04) : 462 - 470
  • [8] Hinchliffe SJ, 1998, J IMMUNOL, V160, P3924
  • [9] Genomic structure and chromosome location of the gene encoding mouse CD59
    Holt, DS
    Powell, MB
    Rushmere, NK
    Morgan, BP
    [J]. CYTOGENETICS AND CELL GENETICS, 2000, 89 (3-4): : 264 - 267
  • [10] Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria
    Holt, DS
    Botto, M
    Bygrave, AE
    Hanna, SM
    Walport, MJ
    Morgan, BP
    [J]. BLOOD, 2001, 98 (02) : 442 - 449